Ta strona została przetłumaczona automatycznie i dokładność tłumaczenia nie jest gwarantowana. Proszę odnieść się do angielska wersja za tekst źródłowy.

Modafinil to Optimize the Performance of Cold-Stressed Sleep-Deprived Personnel

14 września 2026 zaktualizowane przez: Harris R. Lieberman, United States Army Research Institute of Environmental Medicine

Environmental and workplace stressors are common and often unavoidable in military operations. Two critical stressors are cold stress and sleep loss. They both can substantially degrade operational effectiveness. Various countermeasures are available to mitigate the adverse effects of these stressors, but due to operational requirements many are of limited use in the field. Modafinil is a drug that mitigates the effects of sleep deprivation and potentially cold stress, and modafinil may prevent performance degradation due to the combination of these stressors. This study will help determine if modafinil alters body-heat production and prevents cognitive and physical performance degradation due to cold stress in rested and sleep-deprived volunteers.

Przegląd badań

Typ studiów

Interwencyjne

Zapisy (Szacowany)

33

Faza

  • Faza 4

Kontakty i lokalizacje

Ta sekcja zawiera dane kontaktowe osób prowadzących badanie oraz informacje o tym, gdzie badanie jest przeprowadzane.

Kontakt w sprawie studiów

Kopia zapasowa kontaktu do badania

Lokalizacje studiów

Kryteria uczestnictwa

Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.

Kryteria kwalifikacji

Wiek uprawniający do nauki

17 lat do 39 lat (Dziecko, Dorosły)

Akceptuje zdrowych ochotników

Tak

Płeć kwalifikująca się do nauki

Wszystko

Opis

Inclusion Criteria:

  • Healthy, men and women aged 18-39 years old. Active-duty military personnel who are 17 years of age will also be allowed to participate.
  • Willing to refrain from the use of caffeine - including dietary supplements that contain caffeine - alcohol, and nicotine 24 hours prior to data collection.
  • Willing to refrain from vigorous physical activity 24 hours prior to data collection.
  • Willing to refrain from any dietary supplement use within one week of initial screening and at any time while enrolled in the study (except a multi-vitamin containing up to 100% RDA).
  • Willing to consume study diets throughout the course of the study.
  • Supervisory approval for participation if permanent party military or a federal employee.

Exclusion Criteria:

  • Use of modafinil or armodafinil in the last 3 months.

  • Known allergy to modafinil or armomodafinil.

  • Current medical profile, or condition, that limits, compromises, or is likely to render inconsistent performance with Grip Strength, Finger Tapping, or cardiovascular exercise on an exercise bike.

  • a. Individuals taking substances that directly interact with modafinil, alertness/attention/concentration, or sympathetic tone: stimulants; decongestants, barbiturates, bronchodilators; SNRIs; opioids; appetite suppressants; anti-obesity medications; b. Individuals taking substances which inhibit CYP3A4 (penicillins; macrolide antibiotics; fluoroquinolones; lomitapide; goldenseal) or MAO inhibitors.

    c. Individuals taking substances which induce CYP3A4 (carbamazepine, phenobarbital, rifampin) to a greater than minimal degree: systemic steroids; anti-gout agents (Exceptions can be recommended to PI for CYP3A4 inducers which do not fall into other listed categories).

    d. Individuals taking substances which are metabolized by CYP450 enzymes 1A2, 2B6, 2C19, or 3A4: immune-suppressant/-modulatory drugs; SSRIs; TCAs; anti-coagulants; antituberculosis agents; antimalarials; antineoplastic agents; antibody-derived drugs; antivirals; azole antifungals; anti-parasitic agents; abortive migraine medications; muscle relaxants; sex hormones or modulators; ibrexafungerp; lefamulin; palovarotene; propranolol.

  • Females who are pregnant or breastfeeding, have a positive- pregnancy test, or plan on becoming pregnant in the next 3 months.

  • Individuals currently taking/using contraceptives (i.e., oral contraceptive pill, intrauterine device, contraceptive implant, contraceptive injection, etc.) other than condoms.

  • Current or history of mental health issues, illness, or condition (i.e., attention deficit hyperactivity disorder, autism spectrum disorder, diagnosed depression or anxiety disorders) that OMSO physician/healthcare provider believes puts the volunteers at increased risk.

  • Current or history of psychosis, or history of suicidal or homicidal ideations within the past 2 years.

  • History of cold injuries or cold-induced asthma.

  • Raynaud's syndrome.

  • Previous hand/finger injuries that impair dexterity and hand function.

  • Metal hardware (plates/screws) in the upper extremities (arm/hands).

  • Abnormal blood count (For example: hemoglobin (Hb) outside of the typical normal values reported by LabCorp in accordance with OMSO (Normal [Hb] Males = 12.6-17.7 g/dL; Females = 11.1-15.9 g/dL) or hematocrit (Hct) outside of the normal ranges (Normal Hct Males = 37.5-51.0%; Females = 34.0-46.6%) levels, presence of abnormal blood laboratory measures (e.g., hemoglobin S or sickle cell traits).

  • Current or history of alcohol abuse (defined as Harmful Use by the World Health Organization), those who meet criteria for alcohol abuse disorder (as outlined in the DSM-5), or other substance abuse (i.e., the use of illegal drugs or the use of prescription or over-the-counter drugs for purposes other than those for which they are meant to be used, or in excessive amounts).

  • Diagnosed sleep disorders (i.e., sleep-apnea, narcolepsy, etc.).

  • Diseases and disorders of the metabolic, cardiovascular, endocrine, neurological, or gastrointestinal systems that in determination of OMSO are expected to interfere with safe conduct of the study.

  • A medical diagnosis of high blood pressure (hypertension).

  • Heart problems or prior heart attack.

  • Regular daily use of medication that may significantly interfere with the study drug or outcomes, as determined by the OMSO physician/healthcare provider.

  • Known allergies to medical adhesives.

  • Difficulty swallowing large pills (self-reported) for those individuals unwilling to utilize the rectal suppository of the telemetric pill.

  • History of obstructive disease of the gastrointestinal tract including (but not limited to) diverticulosis, diverticulitis and inflammatory bowel disease, peptic ulcer disease, Crohn's disease, ulcerative colitis, or previous gastrointestinal surgery, etc. that OMSO physician/healthcare provider believes puts the volunteers at increased risk.

  • Donated blood within 8 weeks prior to study participation.

Plan studiów

Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.

Jak projektuje się badanie?

Szczegóły projektu

  • Główny cel: Leczenie
  • Przydział: Randomizowane
  • Model interwencyjny: Zadanie krzyżowe
  • Maskowanie: Poczwórny

Broń i interwencje

Grupa uczestników / Arm
Interwencja / Leczenie
Komparator placebo: Placebo

200 mg Microcrystalline Cellulose

Placebo intervention to compare to modafinil intervention.

Aktywny komparator: Modafinil

200 mg Modafinil

Evaluating the effect of Modafinil under both sleep deprivation and acute cold exposure on thermoregulation, cognitive flexibility/performance, and dexterity.

Co mierzy badanie?

Podstawowe miary wyniku

Miara wyniku
Opis środka
Ramy czasowe
Height (in)
Ramy czasowe: Familiarization 1 (Day -2)

Height will be measured in inches using a stadiometer.

Familiarization 1 (Day -2)
Body Weight (kg)
Ramy czasowe: Familiarization 1 (Day -2)

Body weight will be measured in kilograms using a calibrated electronic scale.

Familiarization 1 (Day -2)
Body Composition: DXA Fat Mass (lbs)
Ramy czasowe: Familiarization 1 (Day -2)

Fat mass will be measured in kilograms via dual x-ray absorptiometry and used to calculate body fat percentage (fat mass/body weight).

Familiarization 1 (Day -2)
Body Composition: DXA Lean Mass (lbs)
Ramy czasowe: Familiarization 1 (Day -2)

Lean mass will be measured in pounds using dual x-ray absorptiometry.

Familiarization 1 (Day -2)
Body Composition: DXA Bone Mineral Content (lbs)
Ramy czasowe: Familiarization 1 (Day -2)

Bone mineral content (BMC) will be measured in pounds using dual x-ray absorptiometry.

Familiarization 1 (Day -2)
Sleep & Physical Activity
Ramy czasowe: Familiarization 1 to Study Completion (11 Days)

Physical activity and sleep duration will be recorded in minutes per day with a wrist actigraphy monitoring system (Actiwatch Spectrum Plus, Koninklijke Philips N.V., Amsterdam, NL or equivalent device). The accelerometer will be placed on the volunteer's wrist on the first familiarization day, worn continuously throughout the entirety of study participation (11 days total), and returned after a 2-day washout period after the second overnight collection. Activity and sleep measurements recorded by the accelerometer will be utilized to determine sleep/wake times of volunteers throughout the study duration.

Familiarization 1 to Study Completion (11 Days)
Cold Exposure: Core Temperature
Ramy czasowe: Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)

Core temperature will be measured continuously at baseline (room temperature) and during cold exposure using a telemetric thermometer capsule (e-Celsius® Performance Capsule, BodyCap, Saint-Clair, France, or similar). Volunteers will either insert the capsule as a rectal suppository the morning of testing, or opt to ingest orally the night (at least 12 hours) prior to data collection to ensure deep core body temperature is accurately monitored. Volunteers will be removed from testing if core temperature decreases to 35 degrees Celcius or lower.

Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)
Cold Exposure: Skin Temperature
Ramy czasowe: Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)

Skin temperature will be continuously measured in Celcius at baseline (room temperature) and during cold exposure using Thermochron iButtons attached at the volunteer's chest, triceps, hand, thigh, calf, and foot.

Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)
Dexterity: Finger Tapping Task (FTT)
Ramy czasowe: Familiarization 1 (Day -2), Familiarization 2 (Day -1), Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)

The FTT is an approximately 10 minute test used to assess manual dexterity and visuomotor coordination. Volunteers are asked to follow simply motor commands using their hands and fingers while seated using a standard 8-finger QWERTY keyboard position (left fingers resting on ASDF, right fingers resting on JKL;). Volunteers are presented varying finger tap sequences on a computer displaying spatially compatible keys matching the standard position (ASDFJKL;) and asked to press the corresponding key while wearing Army issued contact gloves. The presentation time of cues will be adjusted throughout the task at variable difficulties to assess visuomotor response thresholds. Volunteers are scored based on how quickly finger taps are correctly executed in the presented sequence without errors of omission, commission, or excursions.

Familiarization 1 (Day -2), Familiarization 2 (Day -1), Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)
Cognitive Assessment: Scanning Visual Vigilance
Ramy czasowe: Familiarization 1 (Day -2), Familiarization 2 (Day -1), Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)

Volunteers will continuously scan a computer screen to detect stimuli that are present in irregular intervals approximately every 1 minute. Volunteers will be scored based on whether a stimulus is correctly detected (max score of 30), falsely detected, and the response time in milliseconds when detected. This task is sensitive to low doses of stimulants, nutritional factors, environmental conditions, and sleep loss.

Familiarization 1 (Day -2), Familiarization 2 (Day -1), Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)
Cognitive Assessment: Psychomotor Vigilance Test (PVT)
Ramy czasowe: Familiarization 1 (Day -2), Familiarization 2 (Day -1), Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)

PVT is a 10-minute test of simple visual reaction time used to assess alertness. Volunteers will be scored based on reaction time, correct responses, and lapses (failure to detect stimuli).

Familiarization 1 (Day -2), Familiarization 2 (Day -1), Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)
Cognitive Assessment: Matching to Sample
Ramy czasowe: Familiarization 1 (Day -2), Familiarization 2 (Day -1), Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)

Matching to Sample assesses short-term spatial memory (working memory) and pattern recognition. Volunteers are presented with a series of 8x8 matrices. Each matrix is displayed for 4 seconds, volunteers see a blank screen for 8 to 16 seconds, and then 2 matrices will be presented: one matrix identical to the original, and another slightly different to the original. Volunteers have 15 seconds to select the correct comparison matrix. Volunteers will be scored by correct responses, reaction time, and time-out errors.

Familiarization 1 (Day -2), Familiarization 2 (Day -1), Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)
Cognitive Assessment: Grammatical Reasoning
Ramy czasowe: Familiarization 1 (Day -2), Familiarization 2 (Day -1), Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)

Grammatical reasoning assesses language-based logical reasoning. Volunteers will be presented with either the letters "AB" or "BA" followed by a statement that describes the order of the two letters (e.g. "A precedes B"). The volunteer must select whether the statement is true or false. Volunteers are scored based on accuracy and reaction time, with a max score of 32 correct responses.

Familiarization 1 (Day -2), Familiarization 2 (Day -1), Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)
Cognitive Assessment: Go/No-Go Task
Ramy czasowe: Familiarization 1 (Day -2), Familiarization 2 (Day -1), Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)

The Go/No-Go Task is a 10 minute test that assesses response inhibition. Volunteers will randomly be presented with with a "+" or "x" on their screen during moderate exercise on a stationary bike. Volunteers will be instructed to press a button as quickly as possible in response to one visual stimulus, and withhold a response to the other visual stimulus. Number of correct responses, incorrect responses, and reaction time will be scored.

Familiarization 1 (Day -2), Familiarization 2 (Day -1), Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)
Cognitive Assessment: N-Back Task
Ramy czasowe: Familiarization 1 (Day -2), Familiarization 2 (Day -1), Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)

The N-Bask Task is a 10 minute assessment of working memory. Volunteers will be shown a series of letters on a screen while performing moderate exercise on a stationary bike and asked to mentally take note of the letters shown. Volunteers will then be asked to respond "yes" or "no" by pressing the respective button if the letters currently displayed are the same letters that were displayed either 1, 2, and/or 3 letters back. Correct and incorrect responses will be recorded as a volunteer score.

Familiarization 1 (Day -2), Familiarization 2 (Day -1), Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)
Cognitive Assessment: Task-Switching Task
Ramy czasowe: Familiarization 1 (Day -2), Familiarization 2 (Day -1), Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)

Task-Switching is a 10 minute assessment of cognitive flexibility. Volunteers will switch back and forth randomly between determining if the number presented on the screen is odd or even or if the number presented is above or below 5 while performing moderate exercise on a stationary bike. Volunteers will decipher which task is being performed based on the color of the number presented (pink or blue), and press the corresponding button on their keypad (odd/even or greater than/less than). Volunteers will be scored based on number of correct responses.

Familiarization 1 (Day -2), Familiarization 2 (Day -1), Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)
Physical Performance: Grip Strength
Ramy czasowe: Familiarization 1 (Day -2), Familiarization 2 (Day -1), Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)

Grip strength will be measured in both hands to evaluate manual performance under cold stress using a hand dynamometer. Volunteers were asked to hold the dynamometer in a neutral position (shoulder adducted, elbow flexed to 90 degrees, forearm and wrist neutral) and instructed to squeeze the handle as hard as possible while maintaining a neutral position. Three repetitions will be completed for each hand, alternating hands between each trial. Grip strength for each hand was scored as the mean of the 3 trials, recorded in kilograms.

Familiarization 1 (Day -2), Familiarization 2 (Day -1), Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)

Miary wyników drugorzędnych

Miara wyniku
Opis środka
Ramy czasowe
Cognitive Assessment: Balloon Analogue Risk Task (BART)
Ramy czasowe: Familiarization 1 (Day -2), Familiarization 2 (Day -1), Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)

The BART is used to assess risk-taking behavior, reportedly altered by sleep loss. Volunteers will repeatedly fill simulated balloons with air, and points are awarded each time the balloon inflates with air without "popping it". The more the balloon is inflated, the more points are earned. Volunteers can bank their points at any time. All points accumulated that are not banked will be lost if the balloon pops. Simulated balloons will randomly pop after either 8, 32, or 128 puffs. Volunteers will be scored based on how many balloons are popped in each of these categories.

Familiarization 1 (Day -2), Familiarization 2 (Day -1), Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)
Assessment of Blinding
Ramy czasowe: Cold Exposure (Day 7)

Volunteers will complete a single item exit survey at the end of the second experimental visit to assess the potential of the placebo effect on cognitive and physical performance during cold exposures. Volunteers will be asked to report which experimental session they believe they consumed Modafinil, answering either: session 1, session 2, or not sure.

Cold Exposure (Day 7)
Dietary Intake
Ramy czasowe: Baseline Assessment (Day 0) to Cold Exposure (Day 7)

Volunteers will be prescribed a standardized diet (1.2 g/kg protein, 6 g/kg carbohydrate, 1 g/kg fat) to moderate the potential influence of diet on performance during the experimental visits. Diet prescription will be based on volunteer body mass measured at the first familiarization visit. Volunteers will start diet prescription 48 hours prior to the first experimental visit at baseline assessment, and continue study diet through completion of second experimental visit (8 days total). Study dieticians will prepare individual diets derived from military combat rations (MRE; Meal, Ready-to-Eat) and commercially available food items. Dietary intake will be verified by collecting wrappers/containers and any food or drink that is not entirely consumed will be weighed and accounted for.

Baseline Assessment (Day 0) to Cold Exposure (Day 7)
Cold Exposure: Environmental Symptoms Questionnaire (ESQ)
Ramy czasowe: Familiarization 1 (Day -2), Familiarization 2 (Day -1), Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)

The ESQ was used to determine the effects of exposure to environmental extremes. A modified version of the ESQ was used to assess the effects relevant to cold exposure only. Volunteers were asked to rate statements on a scale from 1 (not at all) to 5 (extreme). Higher scores indicate that the volunteer is experiencing more severe symptoms of cold exposure.

Familiarization 1 (Day -2), Familiarization 2 (Day -1), Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)
Mood Assessment: Profile of Mood States Questionnaire (POMS 2-A)
Ramy czasowe: Familiarization 1 (Day -2), Familiarization 2 (Day -1), Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)

The POMS is a 65-item inventory of mood states that asks volunteers to rate each mood-related adjective on a 5-point scale (0-4) based on how the volunteer is currently feeling. Mood states will be measured on 7 sub-scales: 1) tension/anxiety [TA], 2) depression/dejection [DD], 3) anger/hostility [AH], 4) vigor/activity [VA], 5) fatigue/inertia [FI], 6) confusion/bewilderment [CB], and 7) friendliness. Subscales 1-6 have a potential score of 0-44, while the friendliness subscale has a potential score of 0-40. Total mood disturbance is calculated as: [(TA + DD + AH + FI + CB) - VA] with a potential score of 0-176 . Higher scores indicate that the individual experiences more intense or more frequent negative mood states compared to the general population.

Familiarization 1 (Day -2), Familiarization 2 (Day -1), Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)
Mood Assessment: Buss-Perry Aggression Questionnaire
Ramy czasowe: Familiarization 1 (Day -2), Familiarization 2 (Day -1), Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)

The Buss-Perry Aggression Questionnaire is a 29-item questionnaire that assesses aggressive impulses and thought patterns. Volunteers rank statements on a 5-point scale from "extremely uncharacteristic of me (1)" to "extremely characteristic of me (5)." Aggression is scored on 4 scales: 1) physical aggression, 2) verbal aggression, 3) anger, and 4) hostility. Volunteers are scored for each subscale: physical (scored 9-45), verbal (scored 5-25), anger (scored 7-35), and hostility (scored 8-40), as well as a total score of all items (scored 29-145). Higher scores indicate greater overall aggression.

Familiarization 1 (Day -2), Familiarization 2 (Day -1), Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)
Mood Assessment: Felt Arousal Scale (FAS)
Ramy czasowe: Familiarization 1 (Day -2), Familiarization 2 (Day -1), Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)

The FAS is a one-item inventory measuring feelings of arousal ranging from 1 (low arousal) to 6 (high arousal). Volunteers will be asked to rate their current level of arousal in the final minute of the 15-minute bout of moderate exercise on a stationary bike. Higher scores indicate higher levels of arousal.

Familiarization 1 (Day -2), Familiarization 2 (Day -1), Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)
Mood Assessment: Feeling Scale (FS)
Ramy czasowe: Familiarization 1 (Day -2), Familiarization 2 (Day -1), Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)

The FS is a one-item inventory measuring the extent to which pleasant or unpleasant feelings are currently experiencing. The FS ranges from 5 (very good) to -5 (very bad). Volunteers will complete the FS in the final minute of the 15 minute bout of moderate exercise on a stationary bike. Higher scores indicate the volunteer is experiencing more pleasant feelings while lower scores indicate the volunteer is experiencing more unpleasant feelings.

Familiarization 1 (Day -2), Familiarization 2 (Day -1), Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)
Resilience: Connor-Davidson Resilience Scale (CD-RISC-25)
Ramy czasowe: Familiarization 1 (Day -2)

The CD-RISC-25 was administered at the start of the first familiarization day to assess volunteer resilience as a potential moderating psychological factor. Volunteers were asked to rate 25 items on a scale from "not true at all" (0) to "true nearly all the time" (4). Scores can range from 0-100, with higher scores reflecting greater resilience.

Familiarization 1 (Day -2)
Background Survey
Ramy czasowe: Familiarization 1 (Day -2)

A background survey will be administered at the start of the first familiarization day. Volunteers will be asked to report basic demographic information, tobacco and supplement use, military service, recent physical activity habits, and previous experience with cold exposure as potential moderating variables of cognitive and physical performance during experimental visits.

Familiarization 1 (Day -2)
Adverse Events
Ramy czasowe: Post Overnight Chamber Exposures (Days 5 & 8)

Participants were asked to report any adverse events they may have experienced in the 24 hours following completion of 26-hour overnight cold exposures. Study staff met with volunteers to complete an in-person assessment the morning after overnight collection (Days 4 and 8) and provided a list of expected adverse events associated with Modafinil and sleep deprivation, as well as asked to report any other events/symptoms. Volunteers were asked to report whether they had experienced: trouble sleeping, nausea/other GI issues, headache, numbness or pain in fingers, numbness or pain in toes, other (specify), or no adverse event.

Post Overnight Chamber Exposures (Days 5 & 8)

Współpracownicy i badacze

Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.

Daty zapisu na studia

Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.

Główne daty studiów

Rozpoczęcie studiów (Rzeczywisty)

18 lutego 2025

Zakończenie podstawowe (Szacowany)

1 października 2026

Ukończenie studiów (Szacowany)

1 grudnia 2026

Daty rejestracji na studia

Pierwszy przesłany

6 marca 2026

Pierwszy przesłany, który spełnia kryteria kontroli jakości

14 września 2026

Pierwszy wysłany (Rzeczywisty)

21 września 2026

Aktualizacje rekordów badań

Ostatnia wysłana aktualizacja (Rzeczywisty)

21 września 2026

Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości

14 września 2026

Ostatnia weryfikacja

1 września 2026

Więcej informacji

Terminy związane z tym badaniem

Plan dla danych uczestnika indywidualnego (IPD)

Planujesz udostępniać dane poszczególnych uczestników (IPD)?

NIE

Informacje o lekach i urządzeniach, dokumenty badawcze

Bada produkt leczniczy regulowany przez amerykańską FDA

Tak

Bada produkt urządzenia regulowany przez amerykańską FDA

Nie

produkt wyprodukowany i wyeksportowany z USA

Tak

Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .

Subskrybuj